Entertainment

Aquaron Acquisition Corp. Announces Additional Contribution to Trust Account to Extend Period to Consummate Business Combination

NEW YORK,Jan. 7,2025-- Aquaron Acquisition Corp. (NASDAQ: AQU,the "Company"),a special purpose acquisition company,announced today that HUTURE Ltd. ("Huture") has deposited into th

01-08 Aquaron Acquisition Corp.

GIGABYTE Unveils a Series of Groundbreaking AI Innovations for All at CES 2025

TAIPEI,Jan. 7,2025-- GIGABYTE,the world\'s leading computer brand,unveils groundbreaking AI innovations at CES 2025 with new AI-powered products,AI PCs,NVIDIA® GeForce RTX™ 50 Series graphics car

01-08 GIGABYTE

UGREEN to Showcase Pioneering NASync AI NAS Lineup and More at CES 2025

LAS VEGAS,Jan. 8,2025-- UGREEN,a leading innovator in consumer electronics,is due to showcase its latest innovations at CES 2025 under the theme of "Activate the Possibility of AI." The high

01-08 UGREEN GROUP LIMITED

Lynk & Co Honors Exceptional Global Achievements in 2024

HANGZHOU,China,Jan. 3,2025--On January 1st,Lynk & Co announced its annual sales achievement. With 285,441 units sold worldwide,the brand has achieved a year-on-year growth of approximately 30%. In

01-06

Interest-Driven Consumption Sparks ¥ 500B ACG Goods Market, MINISO Rides the Wave

GUANGZHOU,China,Jan. 3,2025-- MINISO,a global lifestyle brand,recently announced its partnership with "Black Myth: Wukong",winner of the "Best Action Game" and "Players\' Voic

01-06

PacificLight Power Awarded Right to Build New Hydrogen-Ready Combined Cycle Gas Turbine Plant

SINGAPORE,Jan. 3,2025-- PacificLight Power Pte Ltd (PLP) is delighted to announce that it has been awarded the right to build,own,and operate a hydrogen-ready Combined Cycle Gas Turbine (CCGT) facilit

01-06

GRIT Bio Appoints Jie Jia, Ph.D., as Chief Operating Officer

SHENZHEN,China,Jan. 3,2025--Shenzhen GRIT Biotechnology Co.,Ltd.,a leading company in cell therapy globally,today announced the appointment of Jie Jia,Ph.D.,as Chief Operating Officer (COO),effective

01-06

Nona Biosciences Announces Update on Its Collaborator DualityBio's Antibody-Drug Conjugate (ADC) Collaboration with BeiGene

CAMBRIDGE,Mass.,Jan. 3,2025-- Nona Biosciences,a global biotechnology company providing a total solution from "Idea to IND" (I to ITM),today announcedthat BeiGene. Ltd. has exercised its ex

01-06

Innovent Announces Second New Drug Application of DOVBLERON ® (Taletrectinib Adipate Capsule, ROS1 Inhibitor) was Approved by China's National Medical Products Administration

SAN FRANCISCO and SUZHOU,China,Jan. 3,2025-- Innovent Biologics,Inc. ("Innovent") (HKEX: 01801),a world-class biopharmaceutical company that develops,manufactures and commercializes high qua

01-06 Innovent Biologics

Ractigen Therapeutics Announces First Patient Dosed in Phase I Clinical Trial for RAG-17 in SOD1-ALS

NANTONG and SUZHOU,China,Dec. 24,2024-- Ractigen Therapeutics,a clinical-stage pharmaceutical company dedicated to developing RNA-based innovative therapies,today announced the successful dosing of th

01-03